Attached files
| file | filename |
|---|---|
| EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF FEBRUARY 29, 2020 AND - Simulations Plus, Inc. | simulations_ex9903.htm |
| EX-99.01 - AUDITED FINANCIAL STATEMENTS OF LIXOFT, AS OF DECEMBER 31, 2019 - Simulations Plus, Inc. | simulations_ex9901.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Simulations Plus, Inc. | simulations_ex2301.htm |
| 8-K/A - AMENDED CURRENT REPORT - Simulations Plus, Inc. | simulations_8ka1.htm |
Exhibit 99.2
Lixoft
Balance sheet
March 31, 2020
(Unaudited)
in Euro
| ASSETS | ||||
| Current assets | ||||
| Cash and cash equivalents | € | 3,444,365.00 | ||
| Accounts receivable, net | 506,191 | |||
| Prepaid expenses and other current assets | 207,660 | |||
| Total current assets | 4,158,216 | |||
| Long-term assets | ||||
| Property and equipment, net | 28,687 | |||
| Intellectual property, net of accumulated amortization | 841,022 | |||
| Other Intangible assets | 38,500 | |||
| Other assets | 11,540 | |||
| Total assets | € | 5,077,965.00 | ||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
| Current liabilities | ||||
| Accounts payable | € | 39,892.00 | ||
| Accrued payroll and other expenses | 451,497 | |||
| Other Current Liabilities | 82,042 | |||
| Deferred revenue | 1,631,150 | |||
| Total current liabilities | 2,204,581 | |||
| Long-term liabilities | – | |||
| Commitments and contingencies | ||||
| Shareholders' equity | ||||
| Capital stock | 12,738 | |||
| Additional paid-in capital | 121,524 | |||
| Retained earnings | 2,739,122 | |||
| Total shareholders' equity | 2,873,384 | |||
| Total liabilities and shareholders' equity | € | 5,077,965.00 | ||
| 1 |
Lixoft
Statements of Operations
For the three months ended March 31, 2020 and 2019
(Unaudited)
in Euro
| 2019 | 2020 | |||||||
| Net revenues | € | 555,977 | € | 761,677 | ||||
| Cost of revenues | – | 182,648 | ||||||
| Gross profit | 555,977 | 579,029 | ||||||
| Operating expenses | ||||||||
| Selling, general, and administrative | 358,310 | 793,936 | ||||||
| Research and development | – | – | ||||||
| Total operating expenses | 358,310 | 793,936 | ||||||
| Income from operations | 197,666 | (214,908 | ) | |||||
| Other income (expense) | ||||||||
| Interest income (exp) | – | (1,665 | ) | |||||
| Gain on currency exchange | (1,995 | ) | 410 | |||||
| Total other income (expense) | (1,995 | ) | (1,255 | ) | ||||
| Income before income taxes | 195,671 | (216,163 | ) | |||||
| Provision(Benefit) for income taxes | (123,539 | ) | 56,835 | |||||
| Net Income | € | 319,210 | € | (272,998 | ) | |||
| 2 |